|
№
|
Name of the service
|
Unit
|
Price KZT
|
|
Allergy diagnostics
|
|
CDL - Allergens domestic/molecular (А)
|
|
65
|
СDL - Domestic/molecular allergens (A)
|
1 test
|
6 800
|
|
66
|
СDL - Fungal allergens (D)
|
1 test
|
6 800
|
|
67
|
СDL - Tree allergens (T)
|
1 test
|
6 800
|
|
68
|
СDL - Domestic dust allergens (H)
|
1 test
|
6 800
|
|
69
|
СDL - Animal allergens (E)
|
1 test
|
6 800
|
|
70
|
СDL - Inhalant allergens (IP)
|
1 test
|
6 800
|
|
71
|
СDL - Drug allergens ©
|
1 test
|
6 800
|
|
72
|
СDL - Insect allergens (I)
|
1 test
|
6 800
|
|
73
|
СDL - Parasitic allergens (P)
|
1 test
|
6 800
|
|
74
|
СDL - Food-based allergens (F)
|
1 test
|
6 800
|
|
75
|
СDL - Musty allergens (M)
|
1 test
|
6 800
|
|
76
|
СDL - Professional allergens (K)
|
1 test
|
6 800
|
|
77
|
СDL - Other allergens (O)
|
1 test
|
6 800
|
|
78
|
СDL - Weed allergens (W)
|
1 test
|
6 800
|
|
79
|
СDL - Allergens of grasses and grains (G)
|
1 test
|
6 800
|
|
Biochemical screens
|
|
Biochemical blood tests. Protein metabolism
|
|
80
|
Albumen
|
1 test
|
1 900
|
|
81
|
Bence Jones protein in urine
|
1 test
|
58 157
|
|
82
|
Protein immunotyping (M-gradient)
|
1 test
|
51 000
|
|
83
|
Creatinine
|
1 test
|
1 500
|
|
84
|
Uric acid
|
1 test
|
1 800
|
|
85
|
Urea
|
1 test
|
1 700
|
|
86
|
Total protein
|
1 test
|
1 700
|
|
87
|
Blood protein electrophoresis (Protein fractions)
|
1 test
|
5 600
|
|
Biochemical blood tests. Iron metabolism
|
|
88
|
Transferrin
|
1 test
|
4 200
|
|
89
|
Ferritin
|
1 test
|
5 900
|
|
90
|
Total iron-binding capacity of blood serum (TIBC)
|
1 test
|
5 440
|
|
Biochemical blood tests. Lipoprotein metabolism
|
|
91
|
Apolipoprotein A (Apo-A)
|
1 test
|
3 200
|
|
92
|
Apolipoprotein B (Apo-B)
|
1 test
|
3 200
|
|
93
|
High density lipoproteins (HDL)
|
1 test
|
3 400
|
|
94
|
Low-density lipoproteins (LDL)
|
1 test
|
3 000
|
|
95
|
Triglycerides (TG)
|
1 test
|
1 700
|
|
96
|
Cholesterol (CS)
|
1 test
|
2 100
|
|
Biochemical blood tests. Pigment metabolism
|
|
97
|
Total bilirubin
|
1 test
|
1 800
|
|
98
|
Conjugated bilirubin
|
1 test
|
1 800
|
|
Biochemical blood tests. Carbohydrate metabolism
|
|
99
|
Glycosylated hemoglobin (Hemoglobin A1c, HbA1c)
|
1 test
|
4 900
|
|
100
|
Glucose
|
1 test
|
1 500
|
|
101
|
Glucose on the glucometer
|
1 test
|
600
|
|
Biochemical blood tests. Enzymes
|
|
102
|
Alanine aminotransferase (ALT)
|
1 test
|
1 700
|
|
103
|
Alpha amylase
|
1 test
|
3 200
|
|
104
|
Pancreatic amylase
|
1 test
|
5 600
|
|
105
|
Aspartate aminotransferase (AST)
|
1 test
|
3 000
|
|
106
|
Gamma glutamyl transferase (GGTP)
|
1 test
|
4 000
|
|
107
|
Creatinine kinase-MB fraction (CFK-MB)
|
1 test
|
2 900
|
|
108
|
Creatine phosphokinase (CPK)
|
1 test
|
3 000
|
|
109
|
Lactate dehydrogenase (LDH)
|
1 test
|
3 400
|
|
110
|
Alkaline phosphatase (ALP)
|
1 test
|
2 200
|
|
111
|
Lipase
|
1 test
|
4 250
|
|
Biochemical urine tests
|
|
112
|
Glucose in a single urine portion
|
1 test
|
2 200
|
|
113
|
Glucose in daily urine
|
1 test
|
2 400
|
|
114
|
Urine Ca++
|
1 test
|
2 300
|
|
115
|
Urine creatinine
|
1 test
|
2 000
|
|
116
|
Urine Mg++
|
1 test
|
2 000
|
|
117
|
Urine uric acid
|
1 test
|
2 000
|
|
118
|
Urine urea
|
1 test
|
2 200
|
|
119
|
Microalbumin complex (Creatinine/albumin ratio)
|
1 test
|
14 100
|
|
120
|
Relative indices of metabolic disorders (ratio calcium/creatinine, magnesium/creatinine, inorganic phosphorus/creatinine, uric acid/creatinine
|
1 test
|
6 900
|
|
121
|
Relative index of metabolic disorders (calcium/creatinine ratio)
|
1 test
|
4 900
|
|
122
|
Relative index of metabolic disorders (magnesium/creatinine ratio)
|
1 test
|
5 200
|
|
123
|
Relative index of metabolic disorders (inorganic uric acid/creatinine ratio)
|
1 test
|
4 500
|
|
124
|
Relative index of metabolic disorders (inorganic phosphorus/creatinine ratio)
|
1 test
|
4 400
|
|
125
|
Rehberg test
|
1 test
|
5 100
|
|
126
|
Glomerular filtration rate
|
1 test
|
4 000
|
|
127
|
Urine osmolarity
|
1 test
|
1 000
|
|
128
|
Urine phosphorus
|
1 test
|
1 700
|
|
129
|
Urine potassium
|
1 test
|
1 700
|
|
130
|
Sodium urine
|
1 test
|
1 700
|
|
131
|
Chlorine urine
|
1 test
|
1 700
|
|
Biochemistry
|
|
132
|
Blood osmolarity
|
1 test
|
2 500
|
|
Immune status
|
|
133
|
Immunoglobulin A
|
1 test
|
4 000
|
|
134
|
Immunoglobulin G
|
1 test
|
4 000
|
|
135
|
Immunoglobulin M
|
1 test
|
4 000
|
|
136
|
Complement C3
|
1 test
|
5 270
|
|
137
|
Complement C4
|
1 test
|
4 900
|
|
Hemostatic system testings
|
|
138
|
Thrombocyte aggregation with P2Y (PFA 200 analyzer)
|
1 test
|
39 600
|
|
139
|
Thrombocyte aggregation with ADF (PFA 200 analyzer)
|
1 test
|
39 600
|
|
140
|
Thrombocyte aggregation with Epinephrine (PFA 200 analyzer)
|
1 test
|
37 400
|
|
141
|
Activated partial/batch thromboplastin time (APTT/ABTT)
|
1 test
|
2 500
|
|
142
|
Antithrombin III (AT-3)
|
1 test
|
5 200
|
|
143
|
Lupus anticoagulant (Lupus test)
|
1 test
|
7 600
|
|
144
|
Duke bleeding time
|
1 test
|
1 700
|
|
145
|
Clotting time according to Sukharev
|
1 test
|
1 700
|
|
146
|
D-Dimer Exclusion quantification
|
1 test
|
13 900
|
|
147
|
D-dimer (by turbidimetric immunoassay), quantification
|
1 test
|
17 000
|
|
148
|
Coagulogram - complex No. 1 (APTT, INR, PT, PTI, fibrinogen, TT)
|
1 test
|
6 800
|
|
149
|
Coagulogram - complex No. 2 (APTT, INR, PT, PTI, fibrinogen, TT+ SFMC)
|
1 test
|
9 300
|
|
150
|
International normalized ratio (INR)
|
1 test
|
1 800
|
|
151
|
Protein С
|
1 test
|
5 400
|
|
152
|
Prothrombin time (PT)
|
1 test
|
1 700
|
|
153
|
Prothrombin index (PTI)
|
1 test
|
1 700
|
|
154
|
Soluble fibrin-monomer complexes (SFMC)
|
1 test
|
2 500
|
|
155
|
C1 inhibitor
|
1 test
|
20 400
|
|
156
|
Thrombin time (TT)
|
1 test
|
1 800
|
|
157
|
Thromboelastogram with heparinase
|
1 test
|
19 800
|
|
158
|
Thromboelastogram with kaolin
|
1 test
|
15 300
|
|
159
|
Fibrinogen
|
1 test
|
2 500
|
|
160
|
INR/PT/Quick value in capillary blood
|
1 test
|
13 600
|
|
Specific proteins
|
|
161
|
Alpha - 1 - antitrypsin
|
1 test
|
8 100
|
|
162
|
Antistreptolysin O (ASL-O) quantitation
|
1 test
|
4 700
|
|
163
|
Haptoglobin
|
1 test
|
2 700
|
|
164
|
Myoglobin quantification
|
1 test
|
3 600
|
|
165
|
Rheumatoid factor (RF), quantification
|
1 test
|
3 900
|
|
166
|
C-reactive protein (CRP) quantitation
|
1 test
|
4 000
|
|
167
|
Ceruloplasmin
|
1 test
|
6 900
|
|
Electrolytes, mineral metabolism
|
|
168
|
Antibodies to TSH receptors (anti-TSHr, TSH receptor antibodies, a-rTSH)
|
1 test
|
14 600
|
|
169
|
Ionized calcium
|
1 test
|
5 600
|
|
170
|
Serum iron (Fe)
|
1 test
|
3 000
|
|
171
|
Potassium
|
1 test
|
1 700
|
|
172
|
Total calcium (Ca)
|
1 test
|
2 000
|
|
173
|
Acid-base state (ABS) of blood (Blood gases)
|
1 test
|
9 100
|
|
174
|
Magnesium (Mg)
|
1 test
|
2 700
|
|
175
|
Copper (Cu)
|
1 test
|
2 100
|
|
176
|
Sodium
|
1 test
|
1 700
|
|
177
|
Organic phosphorus (P)
|
1 test
|
2 800
|
|
178
|
Chlorine
|
1 test
|
1 700
|
|
179
|
Electrolytes (potassium, sodium, ionized calcium, chlorine) in blood serum
|
1 test
|
7 600
|
|
180
|
Acid-base state of blood, on a portable analyzer of gases, electrolytes and blood metabolites
|
1 test
|
17 000
|
|
Hematological tests
|
|
181
|
LE-phenomenon (LE - cells, lupus cells)
|
1 test
|
5 100
|
|
182
|
Blood test for malarial plasmodium using the “thin smear” and “thick smear” method
|
1 test
|
2 100
|
|
183
|
CBC+DIFF
|
1 test
|
3 700
|
|
184
|
CBC (short) (without WBC)
|
1 test
|
2 000
|
|
185
|
Reticulocyte count
|
1 test
|
2 000
|
|
186
|
Thrombocyte count according to Fonio
|
1 test
|
2 000
|
|
Immune status
|
|
187
|
Indicators of cellular immunity (L/cytes; T-l/cytes-CD3+; T-helper cells-CD3.4+; T-cytotoxic - CD3.8+; B-l/cytes CD3-.19+; Natural killer cells - CD3 -,16,56+)
|
1 test
|
32 300
|
|
188
|
Phagocytosis (oxygen-independent)
|
1 test
|
17 800
|
|
Immunology research
|
|
Vitamins
|
|
189
|
Vitamin D total, 25-OH-VitD
|
1 test
|
11 407
|
|
190
|
Vitamin D3, 25-OH-VitD3
|
1 test
|
11 500
|
|
191
|
Vitamin B12, Cyanocobalamin
|
1 test
|
5 100
|
|
192
|
Active Vitamin B12, Holotranscobalamin
|
1 test
|
10 800
|
|
193
|
Folic acid (Folate)
|
1 test
|
5 200
|
|
Gastropanel BIOHIT
|
|
194
|
Immunological characteristics of the gastric mucosa (Gastropanel: pepsinogen I, pepsinogen II, gastrin-17B, gastrin-17S, Anti-Heli
|
1 test
|
39 100
|
|
Hormones of the pituitary-adrenal system in the blood
|
|
195
|
Adrenocorticotropic hormone (ACTH)
|
1 test
|
7 100
|
|
196
|
Aldosterone
|
1 test
|
7 100
|
|
197
|
Growth hormone (Somatotropic hormone, hGH)
|
1 test
|
8 500
|
|
198
|
Dehydroepiandrosterone sulfate (DHEA-s)
|
1 test
|
8 500
|
|
199
|
Cortisol
|
1 test
|
6 800
|
|
200
|
Catecholamines (adrenaline, noradrenaline, dopamine) in blood plasma by ELISA
|
1 test
|
39 100
|
|
201
|
Melatonin in blood serum by ELISA method, quantitative determination
|
1 test
|
24 600
|
|
Hormones of the pituitary-adrenal system in the urine
|
|
202
|
Adrenaline (epinephrine) in blood serum by ELISA method, quantitative determination
|
1 test
|
24 600
|
|
203
|
Dopamine in blood serum by ELISA method, quantitative determination
|
1 test
|
24 600
|
|
204
|
Noradrenaline (norepinephrine) in blood serum by ELISA method, quantitative determination
|
1 test
|
24 600
|
|
205
|
Vanillyl mandelic acid in daily urine (VMA, 24h urine)
|
1 test
|
9 300
|
|
206
|
Homovanillic acid in daily urine (HVA, 24h urine)
|
1 test
|
9 300
|
|
207
|
Cortisol in daily urine (Cortisol, 24h urine)
|
8 300
|
|
Pancreatic hormones
|
|
208
|
Insulin
|
1 test
|
5 200
|
|
209
|
Binding peptide (C-Peptide)
|
1 test
|
5 900
|
|
Reproductive system hormones
|
|
210
|
Anti-Mullerian hormone, AMH, MIS
|
1 test
|
12 700
|
|
211
|
Sex hormone binding globulin (SHBG)
|
1 test
|
8 100
|
|
212
|
Luteinizing hormone (LH)
|
1 test
|
3 700
|
|
213
|
Progesterone
|
1 test
|
4 200
|
|
214
|
Prolactin
|
1 test
|
3 900
|
|
215
|
Testosterone
|
1 test
|
5 400
|
|
216
|
Follicle stimulating hormone (FSH)
|
1 test
|
3 700
|
|
217
|
Estradiol
|
1 test
|
4 500
|
|
Thyroid hormones
|
|
218
|
Antibodies to thyroglobulin (Anti-Tg)
|
1 test
|
5 900
|
|
219
|
Antibodies to thyroid peroxidase (Anti-TPO)
|
1 test
|
4 900
|
|
220
|
Thyroglobulin (Tg)
|
1 test
|
5 900
|
|
221
|
Thyroid stimulating hormone (TSH)
|
1 test
|
4 200
|
|
222
|
Total thyroxine (total T4)
|
1 test
|
5 100
|
|
223
|
Free thyroxine (FT4)
|
1 test
|
4 400
|
|
224
|
Total triiodothyronine (total T3)
|
1 test
|
4 500
|
|
225
|
Free triiodothyronine (FT3)
|
1 test
|
4 500
|
|
Autoimmune pathology diagnostics (EIA, ECLIA)
|
|
226
|
Antimitochondrial antibodies M2 subtype (AMA-M2)
|
1 test
|
11 500
|
|
227
|
Antineutrophil cytoplasmic antibodies screening (ANCA-screen)
|
1 test
|
12 750
|
|
228
|
Antinuclear antibodies screening (ANA screen)
|
1 test
|
11 500
|
|
229
|
Antinuclear antibodies screening (ANA-Detect)
|
1 test
|
11 500
|
|
230
|
Antibodies to GBM in blood serum by ELISA method
|
1 test
|
14 100
|
|
231
|
Antibodies to beta-2-glycoprotein I (Anti-ß-2 Glycoprotein)
|
1 test
|
11 300
|
|
232
|
Antibodies to double-stranded DNA (a-dsDNA)
|
1 test
|
11 500
|
|
233
|
Antibodies to single-stranded DNA (a-ssDNA)
|
1 test
|
11 500
|
|
234
|
Antibodies to gastric parietal cells (a-Parietal cell IgG)
|
1 test
|
11 500
|
|
235
|
Antibodies to tissue transglutaminase screening (a-tTG IgA,G)
|
1 test
|
11 500
|
|
236
|
Antibodies to elastase (Anti-Elastase)
|
1 test
|
11 500
|
|
237
|
Class A antibodies to Saccharomyces cerevisiae (ASCA IgA)
|
1 test
|
11 500
|
|
238
|
Class G antibodies to Saccharomyces cerevisiae (ASCA IgG)
|
1 test
|
11 500
|
|
239
|
Class G antibodies to histones (a-Histone IgG)
|
1 test
|
12 700
|
|
240
|
Class G antibodies to cardiolipin (A-Cardiolipin IgG)
|
1 test
|
12 700
|
|
241
|
Class G antibodies to modified citrullinated vimentin (A-MCV IgG)
|
1 test
|
13 900
|
|
242
|
Class G antiphospholipid antibodies (AFL IgG)
|
1 test
|
12 500
|
|
243
|
Class M antibodies to cardiolipin (A-Cardiolipin IgM)
|
1 test
|
12 500
|
|
244
|
Class M antiphospholipid antibodies (AFL IgM)
|
1 test
|
11 500
|
|
245
|
Anti-Prothrombin screening
|
1 test
|
11 500
|
|
246
|
Antibodies to insulin (A-insulin)
|
1 test
|
12 700
|
|
247
|
Total antibodies class A, M, G to cardiolipin, screening (A-Cardiolipin total)
|
1 test
|
11 500
|
|
248
|
Extractable nuclear antibodies, extensive assay (ENA combi)
|
1 test
|
37 000
|
|
249
|
Antineutrophil cytoplasmic antibodies, extensive assay (ANCA-combi)
|
1 test
|
57 400
|
|
250
|
Antinuclear antibodies, extensive analysis (ANA combi)
|
1 test
|
41 600
|
|
251
|
Antisperm antibodies (ASA)
|
1 test
|
18 700
|
|
252
|
IgG antibodies to cyclic citrullinated peptide (a-CCP)
|
1 test
|
25 800
|
|
253
|
Antibodies to insulin in blood serum by ELISA method, quantitation
|
1 test
|
8 500
|
|
254
|
Extractable nuclear antibodies, screening (ENA screen)
|
1 test
|
11 000
|
|
255
|
"ANA pro" for semi-quantitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma
|
1 test
|
34 000
|
|
256
|
"ANCA Dot" for the qualitative determination of IgG antibodies to myeloperoxidase (MPO), proteinase 3 (PR-3) and glomerular basement membrane (GBM) in human serum and plasma
|
1 test
|
39 100
|
|
257
|
"ANA 12 LINE" for the qualitative determination of IgG antibodies to nuclear and cytoplasmic antigens in human serum and plasma
|
1 test
|
42 500
|
|
Autoimmune pathology diagnostics (LIA tests)
|
|
258
|
Antibodies in autoimmune vasculitis IMTEC-Vasculitis-LIA (IgG to PR3, MPO and GBM)
|
1 test
|
44 500
|
|
259
|
Antibodies in autoimmune liver diseases IMTEC-Liver-LIA S (IgG to AMA M2, Sp100, LKM1, gp210, LC1 and SLA)
|
1 test
|
22 900
|
|
260
|
Antinuclear antibodies ANA-LIA (IgG to nucleosomes, dsDNA, histones, SmD1, U1-snRNP, SS-A/Ro60kD, SS-A/Ro52kD, SS-B/La, Scl70, CENP-B, Jo1, P0)
|
1 test
|
10 500
|
|
261
|
Antinuclear antibodies ANA-LIA MAXX: IgG to nucleosomes, dsDNA, histones, SmD1, PCNA, P0, SS-A/Ro60 and 52kD, SS–B/La, CENP-B, Scl-70, U1-snRNP, AMA M2, Jo-1, PM-Scl, Mi-2(β), Ku
|
1 test
|
46 900
|
|
262
|
Antibodies in autoimmune myositis IMTEC-Myositis-LIA (IgG to Jo1, Mi2, PM-Scl, U1-snRNP and Ku)
|
1 test
|
23 900
|
|
263
|
Antibodies for celiac disease IMTEC-Celiac Disease-LIA S (IgA and IgG to gliadin, tissue transglutaminase)
|
1 test
|
10 200
|
|
264
|
Antibodies in gastrointestinal diseases Gastro-LIA (IgA and IgG to gliadin, tTG, mannan, PCA, Castle factor)
|
1 test
|
31 900
|
|
Autoimmune pathology diagnostics using indirect immunofluorescence (inDIF)
|
|
265
|
Antikeratin antibodies (AKA) by indirect immunofluorescence (inDIF)
|
1 test
|
14 025
|
|
266
|
Antineutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence (inDIF)
|
1 test
|
10 285
|
|
267
|
Antinuclear factor on the HEp-2 cell line (ANF) by indirect immunofluorescence (inDIF)
|
1 test
|
14 025
|
|
268
|
Antibodies to native DNA (a-nDNA) by indirect immunofluorescence (inDIF)
|
1 test
|
14 025
|
|
269
|
Autoantibodies by the method (nRIF) on a triple substrate (LKM-1, Antibodies to gastric parietal cells, to smooth muscles (F-actin), ANF on the HEp-2 cell line, AMA-M1.9)
|
1 test
|
14 025
|
|
Immune status
|
|
270
|
Alpha interferon in the blood
|
1 test
|
13 600
|
|
271
|
Gamma interferon in the blood
|
1 test
|
13 600
|
|
272
|
Secretory immunoglobulin A in blood serum (sIgA)
|
1 test
|
8 100
|
|
273
|
Total Immunoglobulin E (total IgE)
|
1 test
|
9 000
|
|
274
|
Immunophenotyping of HLA B27 in blood using flow cytometry
|
1 test
|
34 000
|
|
275
|
Interleukin-10
|
1 test
|
11 000
|
|
276
|
Interleukin-2
|
1 test
|
13 600
|
|
277
|
Interleukin-6
|
1 test
|
13 600
|
|
278
|
Interleukin-8
|
1 test
|
11 000
|
|
279
|
Interleukin - 13 (IL-13) in serum and blood plasma
|
1 test
|
29 700
|
|
280
|
Interleukin - 3 (IL-3) in serum and blood plasma
|
1 test
|
52 700
|
|
281
|
Interleukin - 5 (IL-5) in serum and blood plasma
|
1 test
|
29 700
|
|
282
|
Interleukin - 1 beta (IL-1-beta, IL-1-β) in human biological fluids and culture media by ELISA method, quantitation
|
1 test
|
14 900
|
|
283
|
Interleukin - 13 (IL-13, IL-13) in blood serum by ELISA method, quantitation
|
1 test
|
16 100
|
|
284
|
Interleukin - 18 (IL-18, IL-18) in blood serum by ELISA method, quantitation
|
1 test
|
12 900
|
|
285
|
Interleukin - 3 (IL-3, IL-3) in blood serum by ELISA method, quantitation
|
1 test
|
16 100
|
|
286
|
Interleukin - 4 (IL-4, IL-4) in blood serum by ELISA method, quantitation
|
1 test
|
13 200
|
|
287
|
Interleukin - 5 (IL-5, IL-5) in blood serum by ELISA method, quantitation
|
1 test
|
16 100
|
|
288
|
Eosinophil cationic protein (ECP)
|
1 test
|
10 300
|
|
289
|
Tryptase
|
1 test
|
13 200
|
|
Serological markers of coronavirus infection SARS-CoV-2 (COVID-19, 2019-nCoV)
|
|
290
|
IgM antibodies to SARS-CoV-2 (qualitative)
|
1 test
|
7 300
|
|
291
|
IgG antibodies to SARS-CoV-2 (qualitative)
|
1 test
|
7 300
|
|
292
|
nCoV antibodies - Nab (post-vaccination, quantitative)
|
1 test
|
8 500
|
|
293
|
Immunoglobulin G to SARS-CoV-2 (quantitative)
|
1 test
|
8 500
|
|
294
|
Immunoglobulin M to SARS-CoV-2 (quantitative)
|
1 test
|
10 200
|
|
295
|
IgG/IgM antibodies to SARS-CoV-2 (Rapid test) (qualitative)
|
1 test
|
11 000
|
|
296
|
Sars-CoV-2 specific antigen (rapid test) (qualitative)
|
1 test
|
9 100
|
|
Drug monitoring
|
|
297
|
Tacrolimus in blood serum by immunochemiluminescence
|
1 test
|
16 300
|
|
Markers of sepsis
|
|
298
|
Procalcitonin, PCT (quantitation by enzyme immunoassay)
|
1 test
|
14 900
|
|
299
|
Procalcitonin, PCT (quantitation by immunofluorescence method)
|
1 test
|
14 700
|
|
Bone metabolism
|
|
300
|
Osteocalcin (N-MID Osteocalcin)
|
1 test
|
6 800
|
|
301
|
Parathyroid hormone (PTH)
|
1 test
|
6 800
|
|
302
|
Pyrilinks-D (DPD)
|
1 test
|
6 100
|
|
Tumor markers
|
|
303
|
Alpha 1-fetoprotein (AFP)
|
1 test
|
6 100
|
|
304
|
Squamous cell carcinoma antigen (SCC-Ag)
|
1 test
|
6 600
|
|
305
|
Calcitonin
|
1 test
|
8 500
|
|
306
|
Neuron - specific enolase (NSE, NSE) in blood serum by immunochemiluminescence
|
1 test
|
9 000
|
|
307
|
Progastrin releasing peptide (ProGRP)
|
1 test
|
9 000
|
|
308
|
Prostate-specific antigen total (PSA total, PSA total)
|
1 test
|
4 900
|
|
309
|
Prostate-specific antigen free (PSA free)
|
1 test
|
4 500
|
|
310
|
Carcinoembryonic antigen (CEA, CEA)
|
1 test
|
5 700
|
|
311
|
Cancer antigen 72-4 (CA 72-4)
|
1 test
|
11 000
|
|
312
|
Cancer antigen 125 (CA 125)
|
1 test
|
7 100
|
|
313
|
Cancer antigen 15-3 (CA 15-3)
|
1 test
|
6 600
|
|
314
|
Cancer antigen 19-9 (CA 19-9)
|
1 test
|
6 900
|
|
315
|
Cancer antigen 242 (CA 242)
|
1 test
|
13 900
|
|
316
|
Tumor necrosis factor-alpha (TNF-α, α-TNF)
|
1 test
|
9 300
|
|
317
|
Cytokeratin fragment 19 (Cyfra21-1)
|
1 test
|
9 300
|
|
318
|
Human chorionic gonadotropin intact + beta subunit (HCG+beta)
|
1 test
|
9 300
|
|
319
|
Total human chorionic gonadotropin in urine (HCG urine)
|
1 test
|
7 600
|
|
320
|
Total human chorionic gonadotropin (HCG)
|
1 test
|
3 900
|
|
321
|
Human epididymal protein 4 (HE4)
|
1 test
|
11 000
|
|
Other tests
|
|
322
|
Homocysteine (Hcy-SH)
|
1 test
|
11 000
|
|
323
|
Erythropoietin (EPO)
|
1 test
|
7 300
|
|
324
|
Pancreatic elastase content in feces
|
1 test
|
25 500
|
|
Serological markers of brucellosis
|
|
325
|
Class A antibodies to the causative agent of brucellosis
|
1 test
|
6 800
|
|
326
|
Class G antibodies to the causative agent of brucellosis
|
1 test
|
6 800
|
|
327
|
Class M antibodies to the causative agent of brucellosis
|
1 test
|
6 800
|
|
Serological markers of viral hepatitis D
|
|
328
|
Total class M, G antibodies to hepatitis D virus (a-HDV total)
|
1 test
|
5 100
|
|
Serological markers of viral hepatitis A
|
|
329
|
Class M antibodies to hepatitis A virus (a-HAV IgM)
|
1 test
|
4 000
|
|
Serological markers of viral hepatitis B
|
|
330
|
Hepatitis B virus "e" antigen (HBeAg)
|
1 test
|
4 300
|
|
331
|
Class G antibodies to the “e” antigen of the hepatitis B virus (a-HBeAg IgG)
|
1 test
|
3 900
|
|
332
|
Antibodies class G to the nuclear antigen of the hepatitis B virus (a-HBcAg IgG)
|
1 test
|
4 500
|
|
333
|
Antibodies class M to the nuclear antigen of the hepatitis B virus (a-HBcAg IgM)
|
1 test
|
4 400
|
|
334
|
Hepatitis B surface antigen (HBsAg, Australian antigen)
|
1 test
|
4 000
|
|
335
|
Total antibodies class M, G to the “e” antigen of the hepatitis B virus (a-HBeAg total)
|
1 test
|
4 400
|
|
336
|
Total antibodies class M, G to the surface antigen of the hepatitis B virus (a-HBsAg total)
|
1 test
|
4 900
|
|
337
|
Total antibodies class M, G to the nuclear antigen of the hepatitis B virus (a-HBcAg total)
|
1 test
|
5 400
|
|
338
|
НBsAg, Rapid test (Hepatitis B surface antigen, qualitation)
|
1 test
|
3 000
|
|
Serological markers of viral hepatitis C
|
|
339
|
Hepatitis C virus antigen (HCV Ag)
|
1 test
|
14 400
|
|
340
|
Antibodies class M to hepatitis C virus (HCV IgM)
|
1 test
|
5 900
|
|
341
|
Total antibodies class M, G to hepatitis C virus (a-HCV total)
|
1 test
|
4 800
|
|
342
|
a-HCV, Rapid test (Specific antibodies to hepatitis C virus, qualitation)
|
1 test
|
3 200
|
|
Serological markers of HIV infection
|
|
343
|
HIV p24 antigen and antibodies to human immunodeficiency virus types 1, 2 (HIV-1/2, HIV-1/2)
|
1 test
|
5 100
|
|
344
|
Immunochromatic rapid test of the third generation for the determination of antibodies to human immunodeficiency virus types 1 and 2 (a-HIV-1/2)
|
1 test
|
3 400
|
|
345
|
Express test for determining the free antigen HIV-1 p24 antibodies and antibodies to human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2)
|
1 test
|
5 400
|
|
346
|
ELISA for the presence of antibodies to the human immunodeficiency virus (HIV, AIDS center)
|
1 test
|
4 200
|
|
Serological markers of herpes infection
|
|
347
|
Class G antibodies to herpes simplex virus type 8 (HSV-8-IgG)
|
1 test
|
4 500
|
|
348
|
Class G antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgG)
|
1 test
|
5 100
|
|
349
|
Class G antibodies to herpes simplex virus type 1 (HSV-1-IgG)
|
1 test
|
3 600
|
|
350
|
Class G antibodies to herpes simplex virus type 2 (HSV-2-IgG)
|
1 test
|
4 700
|
|
351
|
Antibodies class G to herpes simplex virus type 6, (HHV-6-IgG)
|
1 test
|
5 100
|
|
352
|
Class M antibodies to herpes simplex virus types 1 and 2 (HSV-1,2-IgM)
|
1 test
|
4 700
|
|
353
|
Class M antibodies to herpes simplex virus type 2 (HSV-2-IgM)
|
1 test
|
5 600
|
|
354
|
Antibodies class M to herpes simplex virus type 1 (HSV-1-IgM)
|
1 test
|
4 200
|
|
355
|
Avidity index of class G antibodies to herpes simplex virus types 1 and 2 (HSV–1,2-IgG–Avidity)
|
1 test
|
5 200
|
|
356
|
Avidity index of class G antibodies to herpes simplex virus type 2 (HSV–2-IgG–Avidity)
|
1 test
|
5 200
|
|
Serological markers of infectious mononucleosis
|
|
357
|
Class G antibodies to Epstein-Barr virus early antigen (EBV-EA IgG)
|
1 test
|
5 400
|
|
358
|
Class G antibodies to Epstein-Barr virus nuclear antigen (EBV-NA IgG)
|
1 test
|
5 400
|
|
359
|
Class G antibodies to Epstein-Barr virus capsid antigen (EBV-VCA IgG)
|
1 test
|
5 400
|
|
360
|
Antibodies class M to Epstein-Barr virus capsid antigen (EBV-VCA IgM)
|
1 test
|
5 400
|
|
361
|
Index of avidity of class G antibodies to the capsid antigen of the Epstein-Barr virus (EBV-VCA IgG-Avidity)
|
1 test
|
5 900
|
|
Serological markers of rubella
|
|
362
|
Class G antibodies to rubella virus (Rubella IgG)
|
1 test
|
4 400
|
|
363
|
Class M antibodies to rubella virus (Rubella IgM)
|
1 test
|
4 700
|
|
364
|
Avidity index of class G antibodies to rubella virus (Rubella IgG-Avidity)
|
1 test
|
5 400
|
|
Serological markers of listeriosis
|
|
365
|
Class G antibodies to Listeria monocytogenes
|
1 test
|
3 700
|
|
Serological markers of cytomegalovirus infection
|
|
366
|
Antibodies of class G and M to the immediate early protein of cytomegalovirus (CMV-IEA-IgG/M)
|
1 test
|
6 100
|
|
367
|
Antibodies class G to cytomegalovirus (CMV IgG)
|
1 test
|
6 200
|
|
368
|
Antibodies class M to cytomegalovirus (CMV IgM)
|
1 test
|
6 100
|
|
369
|
Index of avidity of class G antibodies to cytomegalovirus (CMV-IgG-Avidity)
|
1 test
|
5 900
|
|
Serological markers. Antibodies to protozoa, parasites and fungi
|
|
370
|
Class G antibodies to fungi of the genus Candida albicans (Candida albicans IgG)
|
1 test
|
5 900
|
|
371
|
Class A antibodies to Trichomonas (Trichomonas vaginalis IgA)
|
1 test
|
5 900
|
|
372
|
Class G antibodies to Ascaris antigens (Ascaris lumbricoides IgG)
|
1 test
|
5 900
|
|
373
|
Class G antibodies to Aspergillus antigens (Aspergillus IgG)
|
1 test
|
5 900
|
|
374
|
Class G antibodies to Opisthorchis antigens (a-Opistorhide IgG)
|
1 test
|
5 900
|
|
375
|
Class G antibodies to Toxocara antigens (a-Toxocara IgG)
|
1 test
|
5 900
|
|
376
|
Class G antibodies to Trichinella antigens (a-Trichinella IgG)
|
1 test
|
5 900
|
|
377
|
Class G antibodies to Echinococcus unilocular antigens (a-Echinococcus IgG)
|
1 test
|
5 900
|
|
378
|
Class G antibodies to Toxoplasma (Toxoplasma gondii IgG)
|
1 test
|
5 900
|
|
379
|
Class G antibodies to Trichomonas (Trichomonas vaginalis IgG)
|
1 test
|
5 900
|
|
380
|
Class A antibodies to Toxoplasma (Toxoplasma gondii IgA)
|
1 test
|
5 900
|
|
381
|
Class M antibodies to Toxoplasma (Toxoplasma gondii IgM)
|
1 test
|
5 900
|
|
382
|
Avidity index of class G antibodies to Toxoplasma (Toxoplasma gondii IgG–Avidity)
|
1 test
|
4 900
|
|
383
|
Specific circulating immunocomplexes (CICs) containing opisthorchis antigens
|
1 test
|
6 400
|
|
384
|
Total antibodies of class A, M, G to lamblia (a-Lamblia total)
|
1 test
|
5 100
|
|
Serological markers. Bacterial antibodies
|
|
385
|
Class A antibodies to mycoplasma (Mycoplasma hominis IgA)
|
1 test
|
5 100
|
|
386
|
Class A antibodies to ureaplasma (Ureaplasma urealyticum IgA)
|
1 test
|
5 100
|
|
387
|
Class G antibodies to ureaplasma (Ureaplasma urealyticum IgG)
|
1 test
|
5 100
|
|
388
|
Class G antibodies to Helycobacter pylori
|
1 test
|
5 891
|
|
389
|
Class G antibodies to Chlamydia trachomatis heat shock protein (HSP60), diagnosis of early infection
|
1 test
|
3 700
|
|
390
|
Class G antibodies to major outer membrane protein (MOMP) and plasmid protein pgp3 of Chlamydia trachomatis
|
1 test
|
4 400
|
|
391
|
Class G antibodies to mycoplasma (Mycoplasma hominis IgG)
|
1 test
|
5 100
|
|
392
|
Class G antibodies to chlamydia (Chlamydia trachomatis IgG)
|
1 test
|
5 100
|
|
393
|
Class M antibodies to chlamydia (Chlamydia trachomatis IgM)
|
1 test
|
5 100
|
|
394
|
Class A antibodies to chlamydia (Chlamydia trachomatis IgA)
|
1 test
|
5 100
|
|
395
|
Total antibodies class A, M, G to the Cag antigen of Helycobacter pylori
|
1 test
|
5 100
|
|
396
|
Total antibodies class A, M, G to Mycobacterium tuberculosis (a-Mycobacterium Tuberculosis)
|
1 test
|
5 400
|
|
397
|
Total antibodies class A, M, G to syphilis (Treponema pallidum total)
|
1 test
|
5 400
|
|
Specific blood proteins
|
|
398
|
N-terminal pro-brain B-type natriuretic peptide (NT-pro BNP)
|
1 test
|
11 300
|
|
399
|
Troponin I (TNI), quantitation
|
1 test
|
12 500
|
|
400
|
Troponin I high sensitivity (TNI), quantitation
|
1 test
|
14 700
|
|
401
|
Rapid test for the qualitation of Troponin I (TNI) and myoglobin
|
1 test
|
3 900
|
|
402
|
Brain natriuretic peptide (BNP)
|
1 test
|
34 000
|
|
Specific urine proteins
|
|
403
|
Neutrophil gelatinase-associated lipocalin, NGAL
|
1 test
|
10 800
|
|
Microbiological testings
|
|
Bacteriological testings
|
|
404
|
Bacteriological examination of autopsy material
|
1 test
|
11 000
|
|
405
|
Bacteriological examination of biomaterial from the nose for staphylococcus
|
1 test
|
9 300
|
|
406
|
Bacteriological examination of biomaterial for anaerobes
|
1 test
|
9 600
|
|
407
|
Bacteriological examination of biomaterial for yersiniosis
|
1 test
|
9 300
|
|
408
|
Bacteriological examination of biomaterial for meningococcus
|
1 test
|
11 900
|
|
409
|
Bacteriological examination of biomaterial for microflora
|
1 test
|
15 300
|
|
410
|
Bacteriological examination of biomaterial for the presence of the causative agent of diphtheria
|
1 test
|
11 000
|
|
411
|
Bacteriological examination of biomaterial for the presence of fungi with identification of their species
|
1 test
|
10 700
|
|
412
|
Bacteriological examination of stool for cholera (form 30)
|
1 test
|
11 000
|
|
413
|
Bacteriological blood test for sterility using a bacteriological analyzer
|
1 test
|
14 200
|
|
414
|
Bacteriological test for group B streptococcus (GBS)
|
1 test
|
24 600
|
|
415
|
Taking biomaterial for microbiological research
|
1 test
|
2 000
|
|
416
|
Test for intestinal dysbiosis
|
1 test
|
23 800
|
|
417
|
Bacteriological examination of feces for pathogenic and opportunistic intestinal microflora with sensitivity determination
|
1 test
|
8 800
|
|
418
|
Identification of a pure culture of a microorganism using mass spectrometry
|
1 test
|
3 500
|
|
419
|
Bacteriological examination of biomaterial for meningococcus PASTOREX MENINGITIS
|
1 test
|
37 400
|
|
420
|
Bacteriological examination of genital secretions using the Genital SYSTEM method
|
1 test
|
25 500
|
|
421
|
Gene-Xpert Determination of M. tuberculosis and rifampicin resistance
|
1 test
|
62 900
|
|
Sanitary and bacteriological testings
|
|
422
|
Bacteriological air testing (1 room)
|
1 test
|
3 500
|
|
423
|
Bacteriological examination of liquid dosage forms and material for sterility (10 samples)
|
1 test
|
5 600
|
|
424
|
Bacteriological testing swabs from environmental objects for coliform bacteria (coliforms), pathogenic intestinal flora, golden staff
|
1 test
|
2 500
|
|
Sputum examinations
|
|
425
|
Microscopic examination of biomaterial for the presence of acid-fast bacteria (AFB) for suspected tuberculosis
|
1 test
|
4 000
|
|
Parasitological examination of stool
|
|
426
|
Examination of stool for helminth eggs using a fecal parasite concentrator
|
1 test
|
4 200
|
|
427
|
Examination of stool for protozoa and helminth eggs
|
1 test
|
2 700
|
|
Serological diagnosis of syphilis
|
|
428
|
Microreaction
|
1 test
|
2 100
|
|
429
|
Wasserman reaction (RW)
|
1 test
|
6 200
|
|
430
|
Syphilis, Rapid test (Specific antibodies to Treponema pallidum, qualitative determination)
|
1 test
|
5 700
|
|
Molecular biological research (PCR)
|
|
PCR based bacterial infections diagnostics
|
|
431
|
Brucella DNA (DNA Brucella species)
|
1 test
|
8 500
|
|
432
|
DNA of the causative agent of respiratory mycoplasmosis/chlamydia (Mycoplasma pneumoniae/Chlamydophila pneumoniae DNA)
|
1 test
|
10 500
|
|
433
|
Mycobacterium tuberculosis DNA (Mucobacterium tuberculosis DNA)
|
1 test
|
6 100
|
|
434
|
Toxoplasma gondii DNA
|
1 test
|
5 900
|
|
PCR based viral hepatitis diagnostics
|
|
435
|
Hepatitis C virus genotyping: 1a, 1b, 2, 3a, 4b genotypes (HCV Genotype, HCV Genotyping/Subtyping) Genotyping/Subtyping)
|
1 test
|
21 400
|
|
436
|
Hepatitis B virus DNA, qualitaion (HBV DNA Qualitative)
|
1 test
|
14 400
|
|
437
|
Hepatitis B virus DNA, quantitation (HBV DNA viral load, HBV DNA Quant.)
|
1 test
|
20 000
|
|
438
|
Hepatitis D virus RNA, qualitation (HDV RNA Qualitative)
|
1 test
|
16 100
|
|
439
|
Hepatitis C virus RNA quantitation (HCV RNA viral load, HCV RNA Quant.)
|
1 test
|
22 400
|
|
440
|
Hepatitis C virus RNA, qualitation (HCV RNA, RNA HCV Qualitative)
|
1 test
|
15 800
|
|
PCR based viral infections diagnostics
|
|
441
|
PCR based diagnostics of the COVID-19 virus
|
1 test
|
7 500
|
|
442
|
DNA cytomegalovirus (DNA Cytomegalovirus Quant), quantitation)
|
1 test
|
17 000
|
|
443
|
DNA of Gardnerella and others (Florocenosis/bacterial vaginosis) quantitation
|
1 test
|
7 900
|
|
444
|
Human papillomavirus DNA of high carcinogenic risk, screening (HPV DNA, high-risk HPV DNA)
|
1 test
|
17 800
|
|
445
|
Varicella-Zoster virus DNA (VZV DNA, DNA Varicella-Zoster virus, DNA VZV)
|
1 test
|
4 200
|
|
446
|
DNA Rubella virus (DNA Rubella virus)
|
1 test
|
4 400
|
|
447
|
Human papillomavirus DNA 16/18 types (HPV DNA 16/18, DNA НРV 16/18)
|
1 test
|
10 200
|
|
448
|
DNA of herpes simplex virus types 1 and 2 (DNA HSV 1, 2)
|
1 test
|
10 200
|
|
449
|
Epstein-Barr virus DNA (DNA EBV Qualitative), qualitation
|
1 test
|
5 100
|
|
450
|
Epstein-Barr virus DNA (EBV DNA, DNA EBV Quant), quantitation)
|
1 test
|
10 200
|
|
451
|
DNA of ARVI pathogens
|
1 test
|
11 000
|
|
452
|
DNA cytomegalovirus (DNA Cytomegalovirus)
|
1 test
|
12 700
|
|
453
|
Determinating DNA of the causative agent of PERTUSSIS
|
1 test
|
8 840
|
|
454
|
Determinating DNA of the causative agent of Pneumocystis
|
1 test
|
8 500
|
|
PCR based urogenital infections diagnostics
|
|
455
|
DNA of ureaplasma and mycoplasma (Florocenosis/ureaplasma, mycoplasma) (quantitation)
|
1 test
|
7 800
|
|
456
|
Candida DNA (Florocenosis/Candida) (quantitation)
|
1 test
|
7 600
|
|
457
|
Candida albicans DNA
|
1 test
|
6 200
|
|
458
|
Chlamydia trachomatis DNA
|
1 test
|
6 200
|
|
459
|
Gardnerella vaginalis DNA
|
1 test
|
6 200
|
|
460
|
Mycoplasma genitalum DNA
|
1 test
|
6 200
|
|
461
|
Mycoplasma hominis DNA
|
1 test
|
6 200
|
|
462
|
Neisseria gonorrhoeae DNA
|
1 test
|
6 200
|
|
463
|
Trichomonas vaginalis DNA
|
1 test
|
6 200
|
|
464
|
Ureaplasma species DNA
|
1 test
|
6 200
|
|
PCR based other infections diagnostics
|
|
465
|
DNA of helminthiasis pathogens (Ascaris lumbricoides, Enterobius vermicularis, Opisthorchis felineus, Taenia solium, Diphyllobothrium latum)
|
1 test
|
12 800
|
|
466
|
DNA from pathogens of protozoal infections (Lamblia Intestinalis Giardia, Blastocystis hominis, Dientamoeba fragilis, Isospora belli, Cryptosporidium parvum, Entamoeba histolytica)
|
1 test
|
12 800
|
|
General clinical studies
|
|
General clinical stool examinations
|
|
467
|
Examination of feces for occult blood
|
1 test
|
3 700
|
|
468
|
Test for Helicobacter pylori antigen (qualitation, rapid test)
|
1 test
|
7 100
|
|
469
|
Calprotectin (qualitation, rapid test)
|
1 test
|
11 000
|
|
470
|
Calprotectin (quantitation by enzyme immunoassay)
|
1 test
|
17 000
|
|
471
|
Coprogram
|
1 test
|
5 100
|
|
General clinical urine tests
|
|
472
|
Protein in daily urine
|
1 test
|
2 800
|
|
473
|
Urinalysis according to Nechiporenko
|
1 test
|
3 400
|
|
474
|
Daily urinу analysis according to Zimnitsky
|
1 test
|
3 400
|
|
475
|
Microalbumin (MAU) in a single portion of urine (semi-quantitative determination)
|
1 test
|
1 700
|
|
476
|
General sputum analysis
|
1 test
|
3 400
|
|
477
|
General urinalysis (UCA)
|
1 test
|
2 300
|
|
478
|
Rhinocytogram (cellular composition)
|
1 test
|
3 700
|
|
479
|
Three-glass urine sample
|
1 test
|
2 200
|
|
Сlinical examinations of urethral and vaginal discharge
|
|
480
|
Microscopic examination of urethral discharge (urethral smear)
|
1 test
|
3 900
|
|
481
|
Microscopic examination of prostate secretion (prostate gland)
|
1 test
|
3 900
|
|
482
|
Determining the degree of purity of a gynecological smear
|
1 test
|
5 100
|
|
483
|
Spermogram with determination of sperm morphology
|
1 test
|
14 400
|
|
484
|
MAR test
|
1 test
|
12 700
|
|
Сlinical examinations of other biomaterial
|
|
485
|
Biomaterial examination for the genus Demodex (Demodex)
|
1 test
|
3 400
|
|
486
|
Biomaterial examination for the pathogenic fungi
|
1 test
|
2 800
|
|
487
|
Clinical examination of cerebrospinal fluid (CSF, cerebrospinal fluid)
|
1 test
|
2 000
|
|
488
|
Clinical examination of duodenal contents (bile)
|
1 test
|
4 700
|
|
489
|
Clinical examination of serous cavities fluids and cysts (exudate, transudate)
|
1 test
|
2 200
|
|
490
|
Microscopic examination of a smear stained according to Romanovsky
|
1 test
|
3 200
|
|
491
|
Microscopic examination of skin scrapings for the scabies mites.
|
1 test
|
3 400
|
|
Genomic laboratory services
|
|
492
|
Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 52 key genes connected with canceration, pan
|
1 test
|
765 000
|
|
493
|
Molecular genetic analysis of mutations, chimeric transcripts and copy number variants in 69 key genes connected with the development of myeloid disorders
|
1 test
|
816 000
|
|
494
|
Molecular genetic diagnosis of V600E mutations in the BRAF gene from tumor cells enclosed in paraffin sections
|
1 test
|
49 300
|
|
495
|
Molecular genetic diagnosis of mutations in the ALK gene from tumor cells enclosed in paraffin sections
|
1 test
|
76 500
|
|
496
|
Whole exome sequencing of human DNA to search for a presumably hereditary disease with interpretation of the results
|
1 test
|
1 870 000
|
|
497
|
Mutations in HLA CLASS II genes - DQ2, DQ8, DQA1*05 in celiac disease using real-time PCR
|
1 test
|
153 000
|
|
498
|
FISH diagnostics of bone marrow cells to identify the chimeric gene BCR/ABL t(9;22), in CML and ALLrh+
|
1 test
|
85 000
|
|
499
|
FISH diagnosis of bladder cancer to detect aneuploidy of chromosomes 3, 7, 17 and deletion of the 9p21 locus
|
1 test
|
125 800
|
|
500
|
FISH diagnosis of numerical chromosomal pathologies 13, 18, 21, X and Y in amniotic fluid
|
1 test
|
100 300
|
|
501
|
Qualitation of the chimeric gene BCR/ABL-t(9;22) using real-time PCR
|
1 test
|
27 200
|
|
502
|
Quantitative determination of the BCR/ABL-t(9;22) chimeric gene using real-time PCR
|
1 test
|
45 900
|
|
503
|
Molecular genetic diagnosis using MLPA method of large deletions/duplications in the SMN1 and SMN2 genes associated with spinal muscular atrophy
|
1 test
|
119 800
|
|
504
|
Minimal residual disease
|
1 test
|
45 900
|
|
505
|
Mutation in the DMD gene in Duchenne muscular dystrophy using the MLPA method
|
1 test
|
119 800
|
|
506
|
Standard cytogenetic research (karyotyping) of peripheral blood cells
|
1 test
|
51 000
|
|
507
|
Quantitative and qualitative molecular genetic diagnosis of the chimeric gene BCR/ABL-t(9;22), determination of the type of BCR/ABL gene transcript in hemo
|
1 test
|
73 100
|
|
508
|
Molecular genetic analysis (genotyping) of mutations in genes associated with the risk of arterial hypertension and diabetes mellitus 2 s
|
1 test
|
101 500
|
|
509
|
Molecular genetic diagnosis of V617F mutations in the JAK2 gene in myeloproliferative diseases
|
1 test
|
45 900
|
|
510
|
Molecular genetic assessing the ratios of human microorganisms (microbiome)
|
1 test
|
283 900
|
|
511
|
Molecular genetic prenatal diagnosis of amniotic fluid cells for aneuploidy of chromosomes 13, 18, 21, X, Y
|
1 test
|
95 200
|
|
512
|
Molecular genetic analysis (genotyping) of mutations in genes associated with changes in pharmacological response
|
1 test
|
101 500
|
|
513
|
Molecular genetic analysis of mutations in 12 genes associated with epidermolysis bullosa
|
1 test
|
297 500
|
|
514
|
Molecular genetic analysis of sensitivity to imatinib for patients with the Ph chromosome in CML and ALLPh+
|
1 test
|
49 300
|
|
515
|
Preimplantation molecular genetic screening of embryos for chromosomal pathologies on 24 chromosomes
|
1 test
|
187 000
|
|
516
|
Molecular genetic diagnosis of polymorphism for susceptibility genes PNPLA3 and TM6SF2 in non-alcoholic steatohepatitis
|
1 test
|
24 100
|
|
517
|
Mutations in the BRCA gene Oncomine Research Assay
|
1 test
|
542 300
|
|
518
|
Mutations, chimeric transcripts and copy number variants in 161 genes associated with canceration, ONCOMINE Comprehensive ASSAY panel
|
1 test
|
748 000
|
|
519
|
Genealogical origin by Y chromosome
|
1 test
|
133 400
|
|
520
|
Mutations in the FLT3 gene (ITD, TKD - D835F) by molecular genetic method
|
1 test
|
54 400
|
|
521
|
JAK2 gene mutations in exon 12 by MLPA method (fragment analysis)
|
1 test
|
76 500
|
|
522
|
Mutation in the PIK3CA gene using a molecular genetic method
|
1 test
|
76 500
|
|
523
|
Mutations in the CFTR gene in cystic fibrosis
|
1 test
|
121 500
|
|
524
|
Individual sensitivity to warfarin
|
1 test
|
63 700
|
|
525
|
Microdeletions (fragment analysis) using the MLPA method for delayed psychomotor development
|
1 test
|
119 800
|
|
526
|
Genotyping in Amyotrophic Lateral Sclerosis
|
1 test
|
73 100
|
|
527
|
Mutations in the KRAS gene
|
1 test
|
171 700
|
|
528
|
Molecular genetic analysis for microsatellite instability (MSI)
|
1 test
|
193 800
|
|
529
|
Fetal Rh factor in maternal blood
|
1 test
|
79 000
|
|
530
|
Mutations in freely circulating tumor DNA
|
1 test
|
1 020 000
|
|
531
|
Mutations in the NF1 gene in neurofibromatosis using the MLPA method
|
1 test
|
367 200
|
|
532
|
Chimeric gene KIAA-BRAF, BRAF V600E by MLPA
|
1 test
|
153 000
|
|
533
|
ERBB2 (HER2) gene amplification
|
1 test
|
136 000
|
|
534
|
Non-invasive prenatal testing for the risk of aneuploidies (chromosomes 13,18,21)
|
1 test
|
255 000
|
|
535
|
Determinating amplification of the CD274(PDL1) gene
|
1 test
|
153 000
|
|
Gliomas diagnostics
|
|
536
|
Aberrant methylation (MGMT)
|
1 test
|
77 300
|
|
537
|
Mutation in the IDH1-IDH2 gene
|
1 test
|
77 300
|
|
538
|
WNT mutation, SHH activation
|
1 test
|
106 200
|
|
539
|
Mutation in the CDKN2A/2B gene
|
1 test
|
77 300
|
|
540
|
Mutation in the EGFR gene
|
1 test
|
77 300
|
|
541
|
Mutation in the ATRX gene
|
1 test
|
77 300
|
|
542
|
Mutation in the TP53 gene
|
1 test
|
77 300
|
|
543
|
Co-expression of 1p-19q
|
1 test
|
77 300
|
|
544
|
H3K27 mutation
|
1 test
|
178 500
|
|
545
|
Mutation in the MYCN gene
|
1 test
|
77 300
|
|
546
|
RELA fusion mutation
|
1 test
|
155 500
|
|
547
|
C19MC gene, miRNA profiling
|
1 test
|
60 300
|
|
548
|
Mutation in the VEGF gene
|
1 test
|
71 400
|
|
549
|
Panel "Glioma" (Mutational status of tumor cells in gliomas)
|
1 test
|
731 000
|
|
550
|
Determinating mutations in the FGFR gene
|
1 test
|
102 000
|
